» Authors » C Bizzarri

C Bizzarri

Explore the profile of C Bizzarri including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 64
Citations 679
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rava L, Fintini D, Mariani M, Deodati A, Inzaghi E, Pedicelli S, et al.
J Endocrinol Invest . 2023 May; 46(12):2555-2562. PMID: 37204691
Purpose: Testing 1-h glucose (1HG) concentration during oral glucose tolerance test is cost-effective to identify individuals at risk of incident type 2 diabetes. Aim of the study was to define...
2.
Garelli S, Dalla Costa M, Sabbadin C, Barollo S, Rubin B, Scarpa R, et al.
J Endocrinol Invest . 2021 May; 44(11):2493-2510. PMID: 34003463
Background: Autoimmune Polyglandular Syndrome type 1 (APS-1) is a rare recessive inherited disease, caused by AutoImmune Regulator (AIRE) gene mutations and characterized by three major manifestations: chronic mucocutaneous candidiasis (CMC),...
3.
Bizzarri C, Colabianchi D, Giannone G, Di Luigi L, Cappa M
J Endocrinol Invest . 2020 Oct; 44(6):1283-1289. PMID: 33000388
Purpose: Exercise represents a physiological stimulus that initiates the coordinated responses of hypothalamic-pituitary axis and sympathetic nervous system. Aims of the study were: 1) to analyze the response of GH,...
4.
Luordi C, Maddaloni E, Bizzarri C, Pedicelli S, Zampetti S, DOnofrio L, et al.
J Endocrinol Invest . 2019 Jul; 43(1):101-107. PMID: 31347024
Purpose: To evaluate the relationship between wrist circumference, markers of adipose dysfunction, and cardiovascular risk in youths with obesity. Methods: In this cross-sectional study, we measured body mass composition by...
5.
Fintini D, Pedicelli S, Bocchini S, Bizzarri C, Grugni G, Cappa M, et al.
J Endocrinol Invest . 2017 Nov; 41(6):739-742. PMID: 29101669
Purpose: Obesity, insulin resistance, and puberty seem to influence and been inversely associated with 25-hydroxy vitamin D (25OHD) levels. To our knowledge, a study on 25OHD in children and adolescents...
6.
Bizzarri C, Lonero A, Delvecchio M, Cavallo L, Faienza M, Giordano M, et al.
J Endocrinol Invest . 2017 Aug; 41(3):325-331. PMID: 28819753
Purpose: Growth retardation is a common complication of chronic kidney disease (CKD) in children. Treatment with recombinant human growth hormone (rhGH) has been used to help short children with CKD...
7.
Bizzarri C, Paladini A, Benevento D, Fierabracci A, Cappa M
J Endocrinol Invest . 2015 Jun; 38(10):1141-3. PMID: 26062518
Background: A different clinical presentation of type 1 diabetes (T1DM) could be supposed in children belonging to different ethnicities, with or without family history of autoimmunity. Objective: This study investigates...
8.
Bizzarri C, Pedicelli S, Boscherini B, Bedogni G, Cappa M, Cianfarani S
J Endocrinol Invest . 2014 Nov; 38(4):429-36. PMID: 25376365
Purpose: Most children with idiopathic isolated GH deficiency (IGHD) normalize GH response to stimulation tests when retested at the completion of growth. The objective of this study was to test...
9.
Bizzarri C, Bottaro G, Pinto R, Cappa M
Pediatr Endocrinol Rev . 2014 Jul; 11(4):365-73. PMID: 24988689
Background: The survival of children with cancer has grown considerably in recent years resulting in a marked increase of endocrine complications. increasingly recognized problems are metabolic syndrome and diabetes mellitus....
10.
Cirillo G, Marini R, Ito S, Wakamatsu K, Scianguetta S, Bizzarri C, et al.
Br J Dermatol . 2012 May; 167(6):1393-5. PMID: 22612534
No abstract available.